Citigroup initiated coverage on shares of Attovia Therapeutics (NASDAQ:ATTO – Free Report) in a research report sent to investors on Monday, MarketBeat reports. The brokerage issued a buy rating and a $30.00 target price on the stock. A number of other analysts also recently commented on ATTO. Morgan Stanley started coverage on Attovia Therapeutics in […]

Stock analysts at Morgan Stanley began coverage on shares of Attovia Therapeutics (NASDAQ:ATTO – Get Free Report) in a note issued to investors on Monday,Benzinga reports. The brokerage set an “overweight” rating and a $39.00 price target on the stock. Morgan Stanley’s price target indicates a potential upside of 88.41% from the stock’s previous close. […]